Skip to main content

Table 1 Vaccine effectiveness against RVGE hospitalization during the post-vaccine period by age group

From: Effects of the rotavirus vaccine program across age groups in the United States: analysis of national claims data, 2001–2016

Age Group Direct VE, % (95% CI) Indirect VE, %
(95% CI)
Overall VE, %
(95% CI)
Total VE, %
(95% CI)
< 1 80* (70, 87) 79* (66, 87) 88* (82, 92) 96* (93, 97)
1 92* (87, 95) 59* (33, 76) 79* (65, 88) 97* (95, 98)
2 87* (76, 93) 43* (4, 67) 68* (44, 83) 93* (86, 96)
3 96* (89, 99) 42 (− 2, 68) 71* (47, 84) 97* (93, 99)
4 81* (53, 93) 36 (− 25, 68) 59* (22, 79) 88* (70, 96)
0–4 87* (83, 90) 60* (48, 69) 78* (71, 83) 95* (93, 96)
5–9 47 (− 12, 79) 48* (30, 61) 50* (34, 63) 72* (42, 89)
10–14   46* (14, 67) Equivalent to indirect VEa  
15–24   42* (10, 62)  
25–44   56* (36, 70)  
45–64   35* (9, 53)  
All ages    69* (62, 76)  
  1. *Represents significance at the alpha = 0.05 level
  2. aIndirect and overall VE are equivalent for children, adolescents, and adults over 9 years of age because there are no vaccinated individuals in these age groups